Rifampicin in Serious Acinetobacter baumannii InfectionRifampicin in Serious Acinetobacter baumannii Infection

Adding rifampicin to colistin does not help patients survive serious infections with extensively drug-resistant (XDR) Acinetobacter baumannii, an Italian phase III study shows. Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news